Amylin Expands Manufacturing Facility in Ohio
ePT--the Electronic Newsletter of Pharmaceutical Technology
Hamilton, OH (May 2)-Amylin Ohio LLC, a subsidiary of Amylin Pharmaceuticals, is expanding construction at its manufacturing facility in West Chester, Ohio. The expansion increases the company?s total investment to approximately $400 million.
Hamilton, OH (May 2)-Amylin Ohio LLC, a subsidiary of Amylin Pharmaceuticals (San Diego, CA, www.amylin.com), is expanding construction at its manufacturing facility in West Chester, Ohio. The expansion increases the company’s total investment to approximately $400 million.
The manufacturing facility is in the process of being equipped to manufacture the company’s long-acting release formulation of exenatide, which is being developed to treat Type-2 diabetes. The expanded facility is expected to create up to 500 jobs over the next three years.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
